TrialThe Journal of infectious diseases2011

An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).

D W Fitzgerald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.